Table 3.

Cox’s regression analysis for the adverse outcomes

Variables	Adjusted Hazard ratio (95% CI)	P value
MACEs
Age	1.036 (1.020–1.054)	<0.001
Gender	0.997 (0.626–1.587)	0.99
Hypertension	0.945 (0.668–1.336)	0.747
Diabetes	1.318 (0.895–1.942)	0.162
Dyslipidemia	0.361 (0.114–1.147)	0.084
Smoking	1.289 (0.862–1.928)	0.217
Killip classification	1.135 (0.937–1.375)	0.197
LVEF	0.993 (0.977–1.009)	0.379
EAT thickness ≥ 3.5 mm	1.382 (0.973–1.961)	0.07
All-cause mortality
Age	1.098 (1.070–1.128)	<0.001
Gender	0.935 (0.484–1.805)	0.842
Hypertension	1.022 (0.611–1.71)	0.934
Diabetes	1.501 (0.832–2.705)	0.177
Dyslipidemia	0 (0–3.801)	0.97
Smoking	1.768 (0.952–3.282)	0.71
Killip classification	1.329 (1.031–1.714)	0.028
LVEF	0.971 (0.948–0.995)	0.02
EAT thickness ≥ 3.5 mm	1.110 (0.637–1.934)	0.712
Recurrent MI
Age	1.001 (0.965–1.038)	0.966
Gender	0.64 (0.207–1.761)	0.356
Hypertension	0.624 (0.27–1.445)	0.271
Diabetes	0.952 (0.359–2.527)	0.921
Dyslipidemia	0.657 (0.087–4.985)	0.685
Smoking	1.767 (0.661–4.72)	0.256
Killip classification	0.838 (0.472–1.487)	0.546
LVEF	1.017 (0.982–1.053)	0.351
EAT thickness ≥ 3.5 mm	1.661 (0.771–3.577)	0.195
TVR
Age	0.999 (0.978–1.021)	0.932
Gender	1.389 (0.674–2.86)	0.932
Hypertension	0.794 (0.493–1.28)	0.794
Diabetes	1.624 (0.987–2.672)	0.056
Dyslipidemia	0.989 (0.35–2.796)	0.984
Smoking	1.219 (0.7–2.123)	0.484
Killip classification	1.050 (0.792–1.391)	0.734
LVEF	1.007 (0.986–1.027)	0.532
EAT thickness ≥ 3.5 mm	1.868 (1.181–2.953)	0.008

MACEs major adverse cardiovascular events, LVEF left ventricular ejection fraction, EAT epicardial adipose tissue, MI myocardial infarction, TVR target vessel revascularization, CI confidence interval